MENU
CYTK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cytokinetics (CYTK) Ownership - Who owns Cytokinetics?

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
673
Web
https://www.cytokinetics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.86B
P/E Ratio
N/A
Total Cash
818.55M
Projected Growth
N/A
Total Debt
1.29B
Revenue
105.82M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
6.03
Total Debt/Equity
N/A
Revenue/Share
0.87 USD as % of share price
View a ticker or compare two or three
CYTK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in discovery and development of small molecule drug therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
673
Web
https://www.cytokinetics.com